The 2022 World Alzheimer’s Report, a companion report to the previous year’s "Journey through the diagnosis of dementia" focused on the subject of life after diagnosis, exploring treatment, care, and support across 119 essays by global experts. Uncover the challenges and solutions in post-diagnostic care through real stories and data. Learn about the different stages of dementia, the impact on individuals and communities, and the effectiveness of various interventions. Read the full report: https://lnkd.in/duiSPY3z
Alzheimer's Disease International
Non-profit Organizations
The international federation of Alzheimer's and dementia associations around the world.
About us
Alzheimer's Disease International (ADI) is the international federation of Alzheimer associations around the world, in official relations with the World Health Organization. ADI's vision is an improved quality of life for people with dementia and their families throughout the world. Each of our members is a non-profit Alzheimer association supporting people with dementia and their families. ADI aims to make dementia a global health priority, to build and strengthen Alzheimer associations, and to raise awareness about dementia worldwide. Stronger Alzheimer associations are better able to meet the needs of people with dementia and their carers. Key activities • Raising global awareness through World Alzheimer's Month™ (September every year). • Providing Alzheimer associations with training in running a non-profit organization through our Alzheimer University programme. • Hosting an international conference where staff and volunteers from Alzheimer associations meet each other as well as medical and care professionals, researchers, people with dementia and their carers. • Disseminating reliable and accurate information through our website and publications. • Supporting the 10/66 Dementia Research Group's work on the prevalence and impact of dementia in developing countries. ADI is based in London and is registered as a non-profit organization in Illinois, USA.
- Website
-
https://www.alzint.org/
External link for Alzheimer's Disease International
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Nonprofit
- Founded
- 1984
- Specialties
- Dementia charity, Organisational development, Awareness campaigns, International public policy, Knowledge translation, Research dissemination, and Alzheimer's
Locations
-
Primary
Get directions
15 Blue Lion Place
London, SE1 4PU, GB
Employees at Alzheimer's Disease International
-
Michael Lefevre
General Manager at Alzheimer's Disease International
-
Paola Barbarino
CEO at Alzheimers Disease International
-
Raul L Arizaga
Chairman - Former Research Group on Dementia at World Federation Of Neurology
-
Paul Attea
Managing Consultant & Founder, Atcel Consultants | Board Member, Alzheimer's Disease International | Former Board Chair, Alzheimers Association |…
Updates
-
New research commissioned by The Lancet suggests that 45% of cases of dementia could be delayed or reduced. The study also identifies failing eyesight and elevated LDL cholesterol levels as new risk factors. Read more at: https://lnkd.in/eGV8J9tr #Dementia #NeverTooEarly #NeverTooLate
-
-
Are you a dementia researcher looking to make sustainable impact? Are you passionate about making a difference to people living with dementia around the world? Then look no further! ADI is expanding our research team! We are seeking a Research Partnerships Lead to help us grow and develop our research programme and ensure we build capacity to translate research into policy change and impact. To learn more and apply for this role, click here: https://lnkd.in/eZqM9A7z We will be conducting rolling interviews - so don't delay!
-
-
This week, Alzheimer's Disease International's Diego Aguilar and Nicholas House, LLM are attending #AAIC24 in Philadelphia, USA. If you're around, don't hesitate to stop and say hello! 👋 Today, Diego will also be participating in a fireside chat on “Breakthroughs in Alzheimer’s disease: implications for people with Alzheimer’s disease, care partners, and beyond with Marwan Sabbagh" at 12.30 in Grand Salon G-L of the Marriott Downtown. Join us to learn more. #AAIC24 #Alzheimers #Dementia
-
-
Are you a dementia researcher looking to make sustainable impact? Are you passionate about making a difference to people living with dementia around the world? Then look no further! ADI is expanding our research team! We are seeking a Research Partnerships Lead to help us grow and develop our research programme and ensure we build capacity to translate research into policy change and impact. To learn more and apply for this role, click here: https://lnkd.in/eZqM9A7z We will be conducting rolling interviews - so don't delay!
-
-
Are you a dementia researcher looking to make sustainable impact? Are you passionate about making a difference to people living with dementia around the world? Then look no further! ADI is expanding our research team! We are seeking a Research Partnerships Lead to help us grow and develop our research programme and ensure we build capacity to translate research into policy change and impact. To learn more and apply for this role, click here: https://lnkd.in/eZqM9A7z We will be conducting rolling interviews - so don't delay!
-
-
Today, the EMA's advisory committe (CHMP) recomended refusing the marketing authorisation of lecanumab. Read more at: https://lnkd.in/eUPYgsJ7
-
Did you know that ADI has an archive of over 100 reports, webinars, toolkits, infographics and other resources available on our website for our global community to access for free? Whether you are a researcher, educator, campaigner, advocate, carer, policy maker or a person living with dementia, our resources are there to share vital knowlegde and insights to help improve the lives of those with dementia and their care networks globally. Access the full range of our resources, search by type or by region and download or watch for free on our website: https://lnkd.in/gkcCmyvM #Dementia #DementiaResources #GlobalInsights
-
-
At the 18th Annual Congress on Controversies in Neurology (CONy 2024) ADI CEO Paola Barbarino discussed with Video Journal of Dementia (VJDementia) about investment in #dementia and Alzheimer's disease therapeutics. She also expressed concerns that patients are being denied their human right to make informed decisions about their treatment options due to access issues. As populations age, dementia is set to become an even more significant health challenge and is currently the 7th leading cause of death globally. #DementiaTreatments #TimeToActOnDementia #WhatsYourPlan #ADI
In the second extract from the interview I talked about in my post yesterday, I raise concerns about the awareness, accessibility, and affordability of new disease-modifying therapies. High costs may prevent reimbursement for those who could benefit. Even before considering treatment costs, global diagnostic capabilities represent a huge barrier, with many healthcare systems lacking the resources and trained clinicians for accurate and timely diagnosis. I also highlight the scarcity of medical professionals who recognize dementia as a disease, citing the 2019 World Alzheimer’s Report where 62% of respondents did not view dementia as a disease, but a normal part of aging. The lack of understanding extends beyond the general public, affecting medical communities and contributing to the stigma surrounding dementia. This interview took place at the 18th Annual Congress on Controversies in Neurology (CONy 2024) in London, UK and is referring to a broader lecture I gave on the subject. https://lnkd.in/eeqci9CA
Barriers to dementia treatment: awareness, accessibility, and affordability
https://www.youtube.com/
-
ADI is proud to announce this World Alzheimer's Month campaign in September 2024 will gather our global community under the theme ‘Time to act on dementia’ & ‘Time to act on Alzheimer’s’ to focus on raising awareness and addressing the stigma which still exists around the condition, calling on policymakers, health and care professionals, experts, those with lived experience and the general public to take collective action to reduce stigma around the condition. With less than two months to go until the launch of our annual campaign in September, ADI invites our global audience to take advantage of our range of campaign materials, including the World Alzheimer’s Month 2024 toolkit, posters, social media asset and, for the first time, a PDF catalogue that includes direct links all the downloadable materials You can find all of our campaign materials on our website through the link below: https://lnkd.in/eGsXmt4K Make sure to let us what you have planned for World Alzheimer's Month 2024. We look forward to campaigning with you this September. #TimeToActOnDementia #TimeToActOnAlzheimer #WorldAlzMonth
-